References
- Bore1 J F, Feurer C, Gubler H S, et al. Biological effects of cyclosporine A: a new antilymphocytic agent. Agents Actions 1976; 6: 468–75
- Perret C, Wiesner-Merzel L, Haggle R. Immunohisto-chemical analysis of T-cell subsets in the peribulbar and intrabulbar infiltrates of alopecia areata. Acta Derm Venereol (Stockh) 1984; 64: 26–30
- Gupta A K, Ellis C N, Cooper K D, et al. Oral cyclosporine for the treatment of alopecia areata. J Am Acad Dermatol 1990; 22: 242–50
- deProst Y, Teillac D, Paquez F, et al. Placebo-controlled trial of topical cyclosporin in severe alopecia areata. Lancet 1986; 2: 803–4
- Manduit G, Lenvers P, Partherlemy H, et al. Treatment of alopecia areata with topically applied cyclosporin A. Ann Dermatol Venereol 1987; 114: 507–10
- Gilhar A, Pillar T, Etzioni A. Topical cyclosporin A in alopecia areata. Acta Dermatol Venereol (Srockh) 1989; 69: 252–3
- Coulson I H, Holden C A. Topical cyclosporin A in alopecia totalis: failure of therapeutic effect due to lack of penetration. Br J Dermatol 1989; 121(Suppl 34)53–4
- Parodi A, Rebora A. Topical cyclosporine in alopecia areata. Arch Dermatol 1987; 123: 165–6
- Rongioletti F, Guarrera M, Tosti A, et al. Topical cyclosporin A fails to improve alopecia areata — a double blind study. J Dermatol Treat 1992; 3: 13–14
- Egbaria K, Ramachandran C, Kittayanod D, et al. Topical delivery of liposomal IFN. Antimicrob Agents Chemother 1990; 34: 107–10
- Weiner N, Williams N, Birch G, et al. Topical delivery of liposomally encapsulated interferon evaluated in a cutaneous herpes guinea pig model. Antimicrob Agents Chemother 1989; 33: 1217–21
- Mezei M, Gulasekharam V. Liposomes, a selective drug delivery system for the topical route of administration. Lotion Dosage Forum. Life Sci 1980; 26: 1473–7
- Egbaria K, Ramachandran C, Weiner N. Topical delivery of cyclosporin: evaluation of various formulations using in-vitro diffusion studies in hairless mouse skin. Skin Phormacol 1990; 3: 21–8
- Lieb L, Ramachandran C, Egbaria K, et al. Topical delivery enhancement with multilamellar liposomes into pilosebaceous units. J Invest Dermatol 1992; 109: 108–13
- Eisen D, Ellis C N, Duell E A, et al. Effect of topical cyclosporine rinse on oral lichen planus. New Engl J Med 1990; 323: 290–4
- Aldridge R D, Sewell H F, King G, et al. Topical cyclosporin A in nickel contact hypersensitivity: results of a preliminary clinical immunohistochemical investigation. Clin Exp Immunol 1986; 66: 582–9
- Thomson A W, Sewell H F, Aldridge R D. Topical cyclosporin and immunologically-mediated skin disorders. Lancet 1987; 1: 1212
- Thomson A W, Aldridge R D, Sewell H F. Topical cyclosporin in alopecia areata and nickel contact dermatitis (follow up to item 9521). Lancet 1986; 2: 971–2
- Hermann R C, Taylor R S, Ellis C N, et al. Topical ciclosporin for psoriasis: In vitro skin penetration and clinical study. Skin Pharmacol 1988; 1: 246–9
- Carli P, Cattaneo A, Taddei G, et al. Topical cyclosporine in the treatment of vulvar lichen sclerosus: clinical, histologic, and immunohistochemical findings. Arch Dermatol 1992; 128: 1279–80, letter
- Gilhar A, Pillar T, Etzioni A. Topical cyclosporine in male pattern alopecia. J Am Acad Dermatol 1990; 22: 251–3
- Fiedler V C. Alopecia areata: a review of therapy, efficacy, safety and mechanism. Arch Dermatol 1992; 28: 1519–29